Trevi Therapeutics, Inc. financial data

Symbol
TRVI on Nasdaq
Location
195 Church Street, 14 Th Floor, New Haven, CT
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.37K % -4.53%
Debt-to-equity 8.45 % -2.76%
Return On Equity -41.4 % +17%
Return On Assets -38.2 % +16.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 122M shares +67.8%
Common Stock, Shares, Outstanding 122M shares +67.8%
Entity Public Float 180M USD +70.2%
Common Stock, Value, Issued 122K USD +67.1%
Weighted Average Number of Shares Outstanding, Basic 130M shares +29%
Weighted Average Number of Shares Outstanding, Diluted 130M shares +29%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 37.8M USD +19.2%
General and Administrative Expense 13.8M USD +19.7%
Operating Income (Loss) -51.5M USD -19.3%
Nonoperating Income (Expense) 4.18M USD -4.83%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -47.3M USD -22.1%
Income Tax Expense (Benefit) -46K USD -318%
Net Income (Loss) Attributable to Parent -47.3M USD -22%
Earnings Per Share, Basic 0 USD/shares -7.69%
Earnings Per Share, Diluted 0 USD/shares -7.69%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 117M USD +803%
Marketable Securities, Current 86.8M USD +53.6%
Other Assets, Current 1.58M USD +90%
Assets, Current 207M USD +187%
Property, Plant and Equipment, Net 239K USD +20.7%
Operating Lease, Right-of-Use Asset 804K USD -21.9%
Other Assets, Noncurrent 68K USD -75.1%
Assets 208M USD +182%
Accounts Payable, Current 2.97M USD +96.8%
Accrued Liabilities, Current 5.98M USD +21.3%
Liabilities, Current 9.24M USD +36.9%
Operating Lease, Liability, Noncurrent 605K USD -31.6%
Liabilities 9.85M USD +28.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 24K USD
Retained Earnings (Accumulated Deficit) -310M USD -18%
Stockholders' Equity Attributable to Parent 198M USD +200%
Liabilities and Equity 208M USD +182%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -13.5M USD -28.8%
Net Cash Provided by (Used in) Financing Activities 8.71M USD
Net Cash Provided by (Used in) Investing Activities -9.95M USD -23%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 122M shares +67.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -14.7M USD +20.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 117M USD +803%
Deferred Tax Assets, Valuation Allowance 82.4M USD +18.6%
Deferred Tax Assets, Gross 82.8M USD +18.2%
Operating Lease, Liability 891K USD -19%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -47.2M USD -22.2%
Lessee, Operating Lease, Liability, to be Paid 1.03M USD -23.6%
Property, Plant and Equipment, Gross 385K USD +10%
Operating Lease, Liability, Current 286K USD +32.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 380K USD +3.26%
Lessee, Operating Lease, Liability, to be Paid, Year One 371K USD +6.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 137K USD -44.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 95K USD -74.8%
Deferred Tax Assets, Operating Loss Carryforwards 53.8M USD +6.94%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 95K USD -74.8%
Operating Lease, Payments 334K USD +21%
Additional Paid in Capital 508M USD +54.6%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 37K USD +5.71%
Interest Expense 9K USD -99.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%